The top analyst upgrades, downgrades and other research calls from Tuesday include Abbott Labs, Alphabet, Amazon.com, General Electric, Gilead Sciences, Intel, Seagate Technology and U.S. Steel.
24/7 Wall St. has noticed that analysts and investors seem to not be able to get enough of Abbott Laboratories.
Jon C. Ogg The op analyst upgrades, downgrades and other research calls from Thursday include Abbott Labs, Amazon, CME, Foot Locker, GE, Home Depot and Lam Research.
The top analyst upgrades, downgrades and other research calls from Monday include Apple, BHP Billiton, CBS, Eli Lilly, GE, Halliburton, IBM, Schlumberger and Verizon.
It's already the end of the first week of 2018, and the stock market has continued its strong bullish trends into the new year. These 20 stocks have seen multiple positive analyst…
The top analyst upgrades, downgrades and other research calls from Tuesday include Abbott Labs, Delphi, Lululemon, Netflix, Nordstrom, Sirius XM, Disney and Windstream.
Deutsche Bank has a basket of high-tax stocks that could see some big benefits from a tax cut. These five are rated Buy and would be great additions to growth accounts.
The top analyst upgrades, downgrades and other research calls from Thursday include Adobe, Allergan, American Express, Baker Hughes, Nike, Northern Dynasty Minerals, Sprint and Wayfair.
The top analyst upgrades, downgrades and other research calls from Friday include Albermarle, Anadarko, Costco, Cree, Kraft Heinz, Netflix, Valero and Walt Disney.
The top analyst upgrades, downgrades and other research calls from Thursday include Abbott Laboratories, Baxter International, Cisco Systems, National Oilwell Varco, Nucor, Procter & Gamble and Target.
Deutsche Bank raised price targets on two red-hot tech stocks that report earnings this week and another tech and a top health care name that already reported stellar results.
These four large cap leaders that have a value profile look attractive now for investors trying to play it a little safer for the second half of 2017.
The top analyst upgrades, downgrades and other research calls from Wednesday include Abbott Laboratories, Advanced Micro Devices, Chesapeake Energy, Intel, PayPal, Target, Weatherford International and Whiting Petroleum.
With interest rates once again dropping as the geopolitical worries ratchet up, investors are concerned about owning good stocks and receiving dependable dividends. One place that looks very good now is pharmaceuticals.
These five Dividend Aristocrats, if purchased soon, should reward investors with a payout early next quarter.
